Jieming Qu

28.1k total citations · 3 hit papers
80 papers, 16.8k citations indexed

About

Jieming Qu is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, Jieming Qu has authored 80 papers receiving a total of 16.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 26 papers in Epidemiology and 17 papers in Infectious Diseases. Recurrent topics in Jieming Qu's work include Pneumonia and Respiratory Infections (16 papers), Neonatal Respiratory Health Research (12 papers) and COVID-19 Clinical Research Studies (9 papers). Jieming Qu is often cited by papers focused on Pneumonia and Respiratory Infections (16 papers), Neonatal Respiratory Health Research (12 papers) and COVID-19 Clinical Research Studies (9 papers). Jieming Qu collaborates with scholars based in China, United States and New Zealand. Jieming Qu's co-authors include Xinxin Zhang, Min Zhou, Ying Liu, Jingli Wang, Yuan Wei, Nanshan Chen, Ting Yu, Li Zhang, Xuan Dong and Yang Qiu and has published in prestigious journals such as The Lancet, PLoS ONE and Cancer Research.

In The Last Decade

Jieming Qu

78 papers receiving 16.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

2020 14.3k citations Nanshan Chen, Min Zhou et al. The Lancet profile →
Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China

2020 681 citations Jieming Qu et al. profile →
Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score

2019 280 citations Lingxi Guo, Dong Wei et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jieming Qu China	26	10.7k	4.7k	2.4k	2.1k	1.8k	80	16.8k
Min Zhou China	27	11.4k 1.1×	5.3k 1.1×	2.9k 1.2×	1.9k 0.9×	1.8k 1.0×	136	20.5k
Xuan Dong China	24	9.9k 0.9×	4.5k 0.9×	2.2k 0.9×	1.6k 0.8×	1.6k 0.9×	102	16.3k
Fengyun Gong China	11	9.6k 0.9×	4.3k 0.9×	2.2k 0.9×	1.3k 0.7×	1.6k 0.9×	21	14.7k
Yang Han China	17	10.1k 0.9×	4.4k 0.9×	2.2k 0.9×	1.4k 0.7×	1.6k 0.9×	51	15.3k
Yang Qiu China	31	10.6k 1.0×	4.4k 0.9×	2.4k 1.0×	1.6k 0.8×	1.6k 0.9×	94	17.6k
Xinxin Zhang China	32	10.6k 1.0×	4.6k 1.0×	2.6k 1.1×	2.9k 1.4×	1.7k 1.0×	217	19.0k
Nanshan Chen China	6	9.6k 0.9×	4.3k 0.9×	2.1k 0.9×	1.3k 0.6×	1.6k 0.9×	13	14.8k
Hua Chen China	22	12.7k 1.2×	6.4k 1.4×	3.9k 1.6×	2.1k 1.0×	1.3k 0.7×	68	19.5k
Yuan Wei China	30	9.6k 0.9×	4.4k 0.9×	2.3k 0.9×	1.4k 0.7×	1.6k 0.9×	142	17.1k

Countries citing papers authored by Jieming Qu

Since Specialization

Citations

This map shows the geographic impact of Jieming Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieming Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieming Qu more than expected).

Fields of papers citing papers by Jieming Qu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jieming Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieming Qu. The network helps show where Jieming Qu may publish in the future.

Co-authorship network of co-authors of Jieming Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Jieming Qu. A scholar is included among the top collaborators of Jieming Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jieming Qu. Jieming Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Shiyu, Min Zhou, Mingzhe Liu, et al.. (2025). Autologous P63+ lung progenitor cell transplantation in idiopathic pulmonary fibrosis: a phase 1 clinical trial. eLife. 13.

Zhang, Shiyu, Min Zhou, Mingzhe Liu, et al.. (2024). Autologous P63+ lung progenitor cell transplantation in idiopathic pulmonary fibrosis: a phase 1 clinical trial. eLife. 13.

Liu, Donglai, Peng Han, Hao Wang, et al.. (2024). Rapid inference of antibiotic resistance and susceptibility for Klebsiella pneumoniae by clinical shotgun metagenomic sequencing. International Journal of Antimicrobial Agents. 64(2). 107252–107252. 8 indexed citations

Li, Junjie, Wei Feng, Xiang Peng, et al.. (2024). A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) vs piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP). International Journal of Infectious Diseases. 153. 107357–107357. 1 indexed citations

Li, Junjie, Wei Feng, Xiang Peng, et al.. (2023). 2519. A Multi-national Phase 3, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Subjects with Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Ma, Xudong, et al.. (2023). Effectiveness of an artificial intelligence clinical assistant decision support system to improve the incidence of hospital-associated venous thromboembolism: a prospective, randomised controlled study. BMJ Open Quality. 12(4). e002267–e002267. 10 indexed citations

Wang, Xiaoli, Yujian Liu, Jiang Liu, et al.. (2022). A bifunctional electrochemical sensor for simultaneous determination of electroactive and non-electroactive analytes: A universal yet very effective platform serving therapeutic drug monitoring. Biosensors and Bioelectronics. 208. 114233–114233. 22 indexed citations

Guo, Lingxi, Yanyan Song, Ni Li, et al.. (2021). A New Prognostic Index PDPI for the Risk of Pneumonia Among Patients With Diabetes. Frontiers in Cellular and Infection Microbiology. 11. 723666–723666. 1 indexed citations

Mei, Hong, Wei Wang, Yusang Xie, et al.. (2021). Surfaceome CRISPR screen identifies OLFML3 as a rhinovirus-inducible IFN antagonist. Genome biology. 22(1). 297–297. 10 indexed citations

10.

Wang, Yu, Donglan Liu, Huihuang Lin, et al.. (2021). Development of a Broadly Applicable Cas12a-Linked Beam Unlocking Reaction for Sensitive and Specific Detection of Respiratory Pathogens Including SARS-CoV-2. ACS Chemical Biology. 16(3). 491–500. 16 indexed citations

11.

Chen, Nanshan, Min Zhou, Xuan Dong, et al.. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 395(10223). 507–513. 14267 indexed citations breakdown →

12.

Liu, Kaixiong, Dong Liu, Yun Feng, et al.. (2020). Spliceosome-associated protein 130: a novel biomarker for idiopathic pulmonary fibrosis. Annals of Translational Medicine. 8(16). 986–986. 8 indexed citations

13.

Hua, Wei, Wenbo Yang, Wei Wang, et al.. (2020). Risk factors for right ventricular dysfunction in patients with lymphangioleiomyomatosis. International journal of cardiac imaging. 37(2). 439–448. 2 indexed citations

14.

Shi, Yi, Yi Huang, Tiantuo Zhang, et al.. (2019). Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition). Journal of Thoracic Disease. 11(6). 2581–2616. 77 indexed citations

15.

Hou, Dongni, Tianlei Ying, Lili Wang, et al.. (2016). Immune Repertoire Diversity Correlated with Mortality in Avian Influenza A (H7N9) Virus Infected Patients. Scientific Reports. 6(1). 33843–33843. 25 indexed citations

16.

Liu, Kaixiong, Yinggang Zhu, Jing Zhang, et al.. (2012). Probiotics' effects on the incidence of nosocomial pneumonia in critically ill patients: a systematic review and meta-analysis. Critical Care. 16(3). R109–R109. 44 indexed citations

17.

Qin, Zhaohui, Jin‐Fu Xu, Jieming Qu, et al.. (2012). Intrapleural delivery of MSCs attenuates acute lung injury by paracrine/endocrine mechanism. Journal of Cellular and Molecular Medicine. 16(11). 2745–2753. 35 indexed citations

18.

Zhang, Jing, Lian Wu, Jieming Qu, et al.. (2011). Pro-Inflammatory Phenotype Of Copd Fibroblasts Not Compatible With Repair In Copd Lung. Zenodo (CERN European Organization for Nuclear Research). 1 indexed citations

19.

Summah, Hanssa, et al.. (2011). Plasma Orexin-A Levels in COPD Patients with Hypercapnic Respiratory Failure. Mediators of Inflammation. 2011. 1–5. 16 indexed citations

20.

Shao, Changzhou, et al.. (2003). A comparative study of clinical manifestations caused by tuberculosis in immunocompromised and non-immunocompromised patients.. PubMed. 116(11). 1717–22. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact